Radicle Innovation is a privately-held, for-profit entity that's focused on all opportunities having a touch-point in life science and healthcare – where life science refers to all human and animal health with a scientific basis, and healthcare refers to the more commercial nature of transforming life science into practical healthcare applications or paradigms.

Why Radicle Innovation

Radicle Innovation has the proven ability to successfully translate life science and healthcare innovations by leveraging its extensive capabilities, resources, and global collaboration network – productively engaging diverse entities (academic, government, industry), regardless of their operational maturity.

Designed as a highly-collaborative concept through translation company, Radicle Innovation enables those with an entrepreneurial spirit to achieve results in a timely, creative, and cost-effective manner via an agile fusion of art, science, technology and business – maximizing all resources to ensure those opportunities demonstrating great promise of translation are fully engaged and flourishing; otherwise, the opportunity is refocused to ensure success, or quickly defocused.

No matter where you are on the innovation journey


The Conceptualization Stage is sometimes referred to as the Ideation Stage, and it’s where the value proposition for the innovation is formulated.


The Incubation Stage is where the innovation becomes real through research and representation, such as by an experiment, a model, prototype, simulation, or other approach.


The Acceleration Stage is where the necessary resources are leveraged to expedite the innovation research and representations realized during Incubation.


The Innovation Stage is where research is minimized, and development is the focus.


The Qualification Stage is where the innovation is proven and validated by leveraging different types of studies and tests.


The Translation Stage is sometimes referred to as the Deployment Stage, and it’s where the realized innovation is put to use; otherwise, the innovation has little or no perceived value.


The Elaboration Stage is where improvements and modifications are made to the innovation in order to maintain its relevance and value.


The Maturation Stage is where the innovation is maintained, yet its relevance and value have diminished, and often displaced by newer innovations.


About Us

About The Team

Radicle Innovation’s team is experienced and accomplished, consisting of both internal and external (collaborative) resources with diverse backgrounds. Radicle Innovation’s collaborative network consists of thousands of individuals, dozens of academic institutions, hundreds of companies, and dozens of government touchpoints around the globe.


To consistently and successfully translate life science and healthcare innovations.


To significantly transform human and animal health via highly disruptive, incremental, radical and breakthrough innovations.

Core Values

Collaboration – selfless devotion to our commitments.

Corporate responsibility – careful consideration of our decisions, and their consequences as we aspire to better humankind.

Creative energy – a passionate and fearless spirit.

Honorable behavior – the highest possible standards of personal and corporate integrity in all we do.

Openness – to new ideas and visionary thinking.

Cultural Enablers

Meeting commitments – to our colleagues.

Excellence realization – providing a work environment that facilitates, fosters and rewards creative energy.

Continuous improvement – a continual critical look at all aspects of the business, with a view to swift, meaningful change.

Operational freedom – to invent, incubate, accelerate, and achieve.


Branding, Communications, Marketing

Creating, building, promoting, and maintaining one’s brand

Business Development

Deal structuring, executive summaries, lead generation, contract brokering, intellectual property brokering, pitch decks, spinouts, technology commercialization


All aspects of entrepreneurship and innovation education, including establishing an innovation culture, preseed workshops, and technology commercialization


Preseed, seed, angel and venture; plus, sponsored research


Investigation, writing, submission and maintenance

Human Resources

Human capital recruitment, and creating/sustaining an innovation culture


Competition, freedom-to-operate/intellectual property, marketing, regulatory


Guidance at every step of the innovation journey, including seed-accelerator

Opportunity Triage

Comprehensive process to determine the likelihood of success, and value of an innovation

Research, Development, Prototyping

All touchpoints from concept through beta prototyping, including human factors

Strategic Guidance and Planning

Strategy formulation and guidance at every step of the innovation journey


Early stage business model, service model, and product feasibility studies; clinical studies. These are in addition to Landscapes and Opportunity Triage


Verification and validation of business models, service models, and products


14 Mar 2017

Johns Hopkins University

Radicle Innovation President & CEO, Albert Di Rienzo, has been appointed by Johns Hopkins University for the third year in a row to be a Mentor-In-Residence as part of the University’s intellectual property administration center, Johns Hopkins Technology Ventures. Di Rienzo, a 33 year industry veteran who has served on the Johns Hopkins Alliance for Science & Technology Development board since 2007, has been handpicked by the University for his invaluable experience and expertise, and will assist JHTV in identifying and prioritizing technologies within the University that have the...

Read More
28 Dec 2016

Syracuse University Center for Advanced Systems and Engineering

Albert Di Rienzo, President & CEO of Radicle Innovation, will be joining Syracuse University's Center for Advanced Systems and Engineering (CASE) Advisory Board. CASE is New York State’s premier applied research center for interdisciplinary expertise in the broad area of complex information-intensive systems, including: monitoring and control, data mining and analytics, information fusion, data and network security/assurance, information processing, predictive analysis, computational intelligence, wireless communications and networks, social networks, “internet of things,” natural...

Read More


22 Aug 2016

Chief Innovation Officer at Voyce™ Presents Latest Advancements in...

Albert J. Di Rienzo invited to speak to physicians, professors, and students at MIT about life science innovations

CHANTILLY, VA (July X, 2016) – i4C Innovations Inc., dba Voyce, a wholly owned subsidiary of Intersections Inc. (Nasdaq: INTX) and the creator of the Voyce Health and Wellness Management System™ and the Voyce Pro Wellness Monitoring Program™, is...

Read More
06 Apr 2016

Voyce Enhances Research and Development Team for Continued Innovation...

Albert J. Di Rienzo joins as Executive Vice President, Research and Development and Chief Innovation Officer

i4C Innovations Inc., dba Voyce, a wholly owned subsidiary of Intersections Inc. (Nasdaq: INTX) and the creators of the Voyce Health and Wellness Management System™, is pleased to announce the expansion of its research and development team with the addition of Albert J. Di Rienzo...

Read More


24 Dec 2016

9th Annual QED Proof-of-Concept White Paper Selection and Showcase

Designed to provide guidance, facilities, funding, and an outlet for entrepreneurs across 31 academic institutions in Delaware, New Jersey and Pennsylvania, the University City Science Center in Philadelphia, PA, along with its many programs, such as the QED Proof-of-Concept, has supported and promoted considerable economic development as well as innovation by convening its diverse members, which make up a capable, and powerful innovation ecosystem.  This ecosystem sparks the spirt of enterprise, expanding and strenghtening the technology and life science sectors. More specifically, the...

Read More
05 Apr 2016

Albert Di Rienzo to attend the 8th Annual New York State...

With New York State becoming ever more aggressive in attracting and retaining businesses, especially in the Biotechnology sector via Start-up NY, which partners academic institutions with industry, the State has become a formidable competitor, attracting companies, spinouts, venture capital, and talent.  In fact, New York State ranks second among States with adults who have four or more years of college, and second among States for the highest number of scientists and engineers.  Furthermore, New York State continues to be exceptionally strong in academic research, development, and...

Read More



Albert was extremely efficient in quickly understanding our technology, and translating it into a concrete value proposition and business model for a strategic partner recruitment.

Dr. Dorit Arad, Chief Science Officer & Founder, MDSURE

Al Di Rienzo is one of the greatest visionaries I know that doesn't hesitate to put the effort behind a Big vision in the early stage, knowing the effort required to get over the hurdles from R&D to commercial success. I met Al at Blue Highway as we put a Dream Team together, which was comprised of top universities and companies to transform healthcare with radical innovation. Unfortunately, hospitals couldn't manage radical innovation, and the EHR mandates at the same time. However, we learned a lot about the efforts required to integrate hospitals into communities; how to overcome the probelm of "Who Pays;" and how to be persistent and patient for the right market timing for radical innovation.  With healthcare problems now bigger than ever, and costs soaring, we look forward to working with Al and the Radicle Innovation team as we build out SmartStori-Health's novel nonlinear, predictive Artificial Intelligence-based platform - the Right way, with the Right partners, to reduce costs and save lives - starting at the Heat of what matters most, incluiding great relationships with great people like Al.

Joe Zagrobelny, Founder & CEO, SmartStori Health & Communications

We met Al in our pre-manufacture and seed phase, and even from our initial interactions, he has added tremendous value to PlenOptika's journey.  On a variety of fronts- from feedback on pitches and negotiation tactics to warm introductions to key opinion leaders- his enthusiasm and desire to see you succeed is evident.  His varied industry and angel experience affords him a wide network of contacts and diverse perspectives from which to draw critical insights about the ideal path to move forward.  Having Al on your team gives you a leg up and a set of eyes to see through the full potential of your vision, and I would highly recommend working with him if you are committed to the full success of your venture.

Shivang Dave, Chief Executive Officer and Co-Founder of PlenOptika, Inc.

I met Al many years ago as colleagues in the medical imaging industry.  He was then a senior engineering executive and engineering manager, demonstrating deep expertise in the subject matter.  All along, he showed top leadership qualities through alliances and partnerships.  He is now extending the same ideas through the novel concept of creating organizations that link between academic research and the commercial world.  Al first exemplified this novel initiative through Blue Highway, and now through Radicle Innovation, creating a powerful concept that’s far more effective than the traditional academic Technology Transfer model.  By identifying the path to commercialization for novel academic research, raising high risk early commercial funds to tackle novel research for commercialization, and forming key commercial strategic alliances conducive to start at the research stage, and go all the way to money making enterprises, Al has raised the bar, and has created an academic, innovation-based, economic engine.

Raul A. Brauner, Chief Executive Officer & Cofounder, Bio-Tree Systems, Inc.

I have had the opportunity to work with Al Di Rienzo in two distinct settings. I turned to him as an expert in his field to turn an idea into a company, I was very happy with his insight and the team that he brought forward to speak with me. He seemed like a knowledgeable, kind, trustworthy, collaborative individual, and when presented with the opportunity, I decided to reach out to him and work closely with him on two personal projects in academia. Al has a wealth of knowledge, passion, patience and commitment, which I have observed first hand, and I am very pleased with the experience of working with him. I would, and have highly recommended Al to collaborators, friends and family, not only because of what he can bring to the table as an expert in his field, but because of who he is as a person.

Jose H. Flores-Arredondo, M.D., Researcher, Baylor College of Medicine, Houston, TX

I will say that Al Di Rienzo is a treasured friend and one of the nicest people I have ever met. I have worked with him on a variety of projects and in every one of a very diverse group of settings, Al was on the mark, kind, and deft at aligning startups with opportunities. While I can’t yet mention the stealth startup of ours he helped, I can say that his assistance made all of the difference and that startup is well on its way to FDA 510k submission. Al is a first-class, trustworthy and energetic mentor and advisor to medical startups. He has a broad network of helpful folks to call upon – a network I’m proud to be a part of. You cannot go wrong with Al.

Greg Kovacs, PhD., Stanford University Professor, IEEE and AIMBE Fellow, Co-Founder, Cepheid

Al has been an instrumental advisor, expert and technical leader as we maneuver uncharted territory, integrating Ultra-Wide Band technology into a remote monitoring system. Al has provided unprecedented insight and guidance, market knowledge, technical expertise and important introductions for our business. He is one of the most talented yet humble people I have ever had the pleasure of working with, and he remains a trusted member of our board of advisors. I highly recommend working with Al, and consider it a unique and valuable opportunity.

Michael Stanfield, Chairman and Chief Executive Officer, Intersections Inc.

Al has been a trusted mentor & advisor at Abram Scientific since its inception, and has guided us every step of the way to transform a simple idea we had into a product that can revolutionize our target market. His technical guidance and business insights in taking a concept from an idea to a commercially viable value proposition is unparalleled in the industry. His ability to think out-of-the-box, while staying updated on the market and leveraging his industry connections, would be invaluable to anyone looking to launch or commercialize a concept to market. Last but not least, his down-to-earth humble demeanor and ability to work by your side as a colleague made our engagement experience all the more enjoyable and fruitful.  I would highly recommend entrepreneurs and industry professionals to engage with Al and his team at Radicle Innovation for a world-class experience!

Edward F. Brennan, Chief Executive Officer, Abram Scientific

Contact Us

Contact Info

Radicle Innovation, LLC
Post Office Box 572
Manlius, New York 13140


Let's Talk

CAUTION: If you submit any materials or information other than a copy of a filed U.S. patent application with its filing receipt, your very submission could cause Radicle Innovation to acquire rights in your intellectual property. Please carefully review Section 10 of our Terms of Service.